LORRAINE KOSSOL: Open Payments
NPI 1720333818 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 5 payments from 4 companies in 2025. Trend: 2023 $325 · 2024 $34 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $156 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $92 |
| PFIZER INC. | 1 | $21 |
Products named: DUPIXENT, OFEV, AIRSUPRA, PREVNAR 20.
Industry payments across NV — which companies pay providers there.
